Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis

ObjectivesThis study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition).MethodsUsing disease-specific clinician-reported and patient-reported data from two randomised clinical trials of...

Full description

Bibliographic Details
Main Authors: Peter Nash, Ana-Maria Orbai, Tore K Kvien, Dafna Gladman, Chen-Yen Lin, Hitoshi Goto, Julie A Birt
Format: Article
Language:English
Published: BMJ Publishing Group 2020-05-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/6/1/e000928.full
id doaj-e4a7db4415da402e9d3f6ba9d19c5429
record_format Article
spelling doaj-e4a7db4415da402e9d3f6ba9d19c54292020-12-14T14:47:39ZengBMJ Publishing GroupRMD Open2056-59332020-05-016110.1136/rmdopen-2019-000928Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisPeter Nash0Ana-Maria OrbaiTore K Kvien1Dafna GladmanChen-Yen LinHitoshi GotoJulie A BirtSchool of Medicine, Griffith University, Brisbane, QLD, Australia 22 Rheumatology, Diakonhjemmet Hospital, Oslo, Norway ObjectivesThis study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition).MethodsUsing disease-specific clinician-reported and patient-reported data from two randomised clinical trials of patients with psoriatic arthritis (PsA), the fatigue NRS was evaluated for test–retest reliability, construct validity and responsiveness. A responder definition was also explored using anchor-based and distribution-based methods.ResultsTest–retest reliability analyses supported the reproducibility of the fatigue NRS in patients with PsA (intraclass correlation coefficient=0.829). Mean (SD) values at baseline and week 2 were 5.7 (2.2) and 5.7 (2.4), respectively. Supporting construct validity of the fatigue NRS, moderate-to-large correlations with other assessments measuring similar concepts as measured by Sackett’s conventions were demonstrated. Fatigue severity was reduced when the underlying disease activity was improved and reductions remained consistent at week 12 and 24. A 3-point improvement was identified as being optimal for demonstrating a level of clinically meaningful improvement in fatigue NRS after 12–24 weeks of treatment.ConclusionsFatigue NRS is a valid and responsive patient-reported outcome instrument for use in patients with PsA. The established psychometric properties from this study support the use of fatigue NRS in clinical trials and in routine clinical practice. Robust validation of reliability for use in routine clinical practice in treating patients with active PsA in less active disease states and other more diverse ethnic groups is needed.https://rmdopen.bmj.com/content/6/1/e000928.full
collection DOAJ
language English
format Article
sources DOAJ
author Peter Nash
Ana-Maria Orbai
Tore K Kvien
Dafna Gladman
Chen-Yen Lin
Hitoshi Goto
Julie A Birt
spellingShingle Peter Nash
Ana-Maria Orbai
Tore K Kvien
Dafna Gladman
Chen-Yen Lin
Hitoshi Goto
Julie A Birt
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
RMD Open
author_facet Peter Nash
Ana-Maria Orbai
Tore K Kvien
Dafna Gladman
Chen-Yen Lin
Hitoshi Goto
Julie A Birt
author_sort Peter Nash
title Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
title_short Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
title_full Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
title_fullStr Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
title_full_unstemmed Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
title_sort fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
publisher BMJ Publishing Group
series RMD Open
issn 2056-5933
publishDate 2020-05-01
description ObjectivesThis study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition).MethodsUsing disease-specific clinician-reported and patient-reported data from two randomised clinical trials of patients with psoriatic arthritis (PsA), the fatigue NRS was evaluated for test–retest reliability, construct validity and responsiveness. A responder definition was also explored using anchor-based and distribution-based methods.ResultsTest–retest reliability analyses supported the reproducibility of the fatigue NRS in patients with PsA (intraclass correlation coefficient=0.829). Mean (SD) values at baseline and week 2 were 5.7 (2.2) and 5.7 (2.4), respectively. Supporting construct validity of the fatigue NRS, moderate-to-large correlations with other assessments measuring similar concepts as measured by Sackett’s conventions were demonstrated. Fatigue severity was reduced when the underlying disease activity was improved and reductions remained consistent at week 12 and 24. A 3-point improvement was identified as being optimal for demonstrating a level of clinically meaningful improvement in fatigue NRS after 12–24 weeks of treatment.ConclusionsFatigue NRS is a valid and responsive patient-reported outcome instrument for use in patients with PsA. The established psychometric properties from this study support the use of fatigue NRS in clinical trials and in routine clinical practice. Robust validation of reliability for use in routine clinical practice in treating patients with active PsA in less active disease states and other more diverse ethnic groups is needed.
url https://rmdopen.bmj.com/content/6/1/e000928.full
work_keys_str_mv AT peternash fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
AT anamariaorbai fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
AT torekkvien fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
AT dafnagladman fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
AT chenyenlin fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
AT hitoshigoto fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
AT julieabirt fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis
_version_ 1724383639889772544